Danielle R. Cook, Ph.D.
Affiliations: | 2013 | Pharmaceutical Sciences | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
General Biology, Cell Biology, OncologyGoogle:
"Danielle Cook"Parents
Sign in to add mentor| Channing J. Der | grad student | 2013 | UNC Chapel Hill | |
| (Mechanisms of Ect2 Regulation in Cytokinesis and Oncogenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cook DR, Kang M, Martin TD, et al. (2021) Aberrant expression and subcellular localization of ECT2 drives colorectal cancer progression and growth. Cancer Research |
| Yin Y, Boesteanu AC, Binder ZA, et al. (2018) Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas. Molecular Therapy Oncolytics. 11: 20-38 |
| Martin TD, Cook DR, Choi MY, et al. (2017) A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. Cell Reports. 20: 427-438 |
| Yin Y, Boesteanu A, Xu C, et al. (2017) Combinatorial IL13Rα2 chimeric antigen receptor-T cells plus checkpoint blockade to treat solid tumors in murine and canine models. Journal of Clinical Oncology. 35: 152-152 |
| Fraietta JA, Beckwith KA, Patel PR, et al. (2016) Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia. Blood |
| Cook DR, Rossman KL, Der CJ. (2014) Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease. Oncogene. 33: 4021-35 |
| Huff LP, Decristo MJ, Trembath D, et al. (2013) The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation. Genes & Cancer. 4: 460-75 |
| Cook DR, Solski PA, Bultman SJ, et al. (2011) The ect2 rho Guanine nucleotide exchange factor is essential for early mouse development and normal cell cytokinesis and migration. Genes & Cancer. 2: 932-42 |
| Anderson LD, Cook DR, Yamamoto TN, et al. (2011) Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma. Cancer Immunology, Immunotherapy : Cii. 60: 985-97 |
| Anderson LD, Cook DR, Berger C, et al. (2007) Use of Gene-Modified T-Cells as Antigen Presenting Cells (T-APC) for Vaccination Against Myeloma Antigens. Blood. 110: 2758-2758 |